المؤلفون: Yuka Oku, Gouji Toyokawa, Sho Wakasu, Fumihiko Kinoshita, Shinkichi Takamori, Kenji Watanabe, Naoki Haratake, Taichi Nagano, Keisuke Kosai, Kazuki Takada, Airi Fujimoto, Kodo Higashijima, Yoshimasa Shiraishi, Kentaro Tanaka, Hiroaki Takeoka, Masaki Okamoto, Takanori Yamashita, Mototsugu Shimokawa, Fumihiro Shoji, Koji Yamazaki, Tatsuro Okamoto, Takashi Seto, Hitoshi Ueda, Sadanori Takeo, Naoki Nakashima, Isamu Okamoto, Tomoyoshi Takenaka, Tomoharu Yoshizumi

المصدر: Cancer Medicine, Vol 12, Iss 13, Pp 14327-14336 (2023)

مصطلحات موضوعية: chemoimmunotherapy, first‐line immunotherapy, monotherapy, non‐small‐cell lung cancer, prognostic nutritional index, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/dd568051ef63481493a1e9c73bb90058

المؤلفون: Yuke Wu, Xiang He

المصدر: Clinical and Experimental Obstetrics & Gynecology, Vol 51, Iss 7, p 155 (2024)

مصطلحات موضوعية: recurrent and metastatic cervical cancer, advanced cervical cancer, first-line immunotherapy, second-line immunotherapy, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

Relation: https://www.imrpress.com/journal/CEOG/51/7/10.31083/j.ceog5107155; https://doaj.org/toc/0390-6663

URL الوصول: https://doaj.org/article/4f57a1c7c13c48c1bc71f7cdf102b448

المؤلفون: Roxana-Andreea Rahnea-Nita, Radu-Valeriu Toma, Valentin Titus Grigorean, Ionuţ Simion Coman, Violeta Elena Coman, Iancu Emil Pleşea, Anwar Erchid, Gabriel-Petre Gorecki, Gabriela Rahnea-Nita

المصدر: Medicina, Vol 60, Iss 8, p 1225 (2024)

مصطلحات موضوعية: small-cell lung cancer, first-line immunotherapy, reinitiating chemotherapy, Epoetinum alpha, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/8/1225; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

URL الوصول: https://doaj.org/article/ca797b06b5424692bb656fdede04771a

المؤلفون: Seban, Romain-David, Assié, Jean-Baptiste, Giroux-Leprieur, Etienne, Massiani, Marie-Ange, Soussan, Michael, Bonardel, Gérald, Chouaid, Christos, Playe, Margot, Goldfarb, Lucas, Duchemann, Boris, Mezquita, Laura, Girard, Nicolas, Champion, Laurence

المساهمون: Institut Curie Paris, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Clinical Epidemiology and Ageing : Geriatrie Soins Primaires et Santé Publique (CEpiA), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Hôpital Ambroise Paré AP-HP, Hôpital Avicenne AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre cardiologique du Nord (CCN), IMRB - CEPIA/"Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health" Créteil (U955 Inserm - UPEC), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB)

المصدر: ISSN: 2072-6694.

مصطلحات موضوعية: FDG-PET, NSCLC, derived neutrophils to lymphocytes ratio, first-line immunotherapy, prognosis, total metabolic tumor volume, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy

Relation: info:eu-repo/semantics/altIdentifier/pmid/32785166; PUBMED: 32785166; PUBMEDCENTRAL: PMC7463532

الاتاحة: https://hal.sorbonne-universite.fr/hal-02982610
https://hal.sorbonne-universite.fr/hal-02982610v1/document
https://hal.sorbonne-universite.fr/hal-02982610v1/file/cancers-12-02234-v2.pdf
https://doi.org/10.3390/cancers12082234

المؤلفون: Mutlu, H., Bozcuk, H., Artaç, M., Eser, I.

مصطلحات موضوعية: Anti-Ctla-4, Anti-Death Protein 1/Death Protein-Ligand 1, Extensive-Disease Small-Cell Lung Cancer, First-Line İmmunotherapy, Network Meta-Analysis

Relation: Journal of Cancer Research and Therapeutics; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.4103/jcrt.jcrt_721_21; https://hdl.handle.net/20.500.12713/4193; 19; S6; S11; 2-s2.0-85159131253; Q3

الاتاحة: https://hdl.handle.net/20.500.12713/4193
https://doi.org/10.4103/jcrt.jcrt_721_21

المؤلفون: Silvia Schifano, Giuseppina Rosaria Rita Ricciardi, Giuseppe Toscano, Vincenzo Adamo, Tindara Franchina, M. Scaffidi Fonti, E. Pantò, Alessandro Russo, Alessandra Battaglia, G. Lo Certo

مصطلحات موضوعية: Oncology, Chemotherapy, medicine.medical_specialty, Oncogene, business.industry, medicine.medical_treatment, Immune checkpoint inhibitors, Atezolizumab, Avelumab, Durvalumab, First line, Immunotherapy, Nivolumab, NSCLC, Pembrolizumab, Animals, Antibodies, Monoclonal, Carcinoma, Non-Small-Cell Lung, Humans, Immunotherapy, Lung Neoplasms, Hematology, Immunotherapy, medicine.disease, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Internal medicine, medicine, 030212 general & internal medicine, Non small cell, Lung cancer, business, Predictive biomarker

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af29430e651161f0b48122cd4866564f
http://hdl.handle.net/11570/3169092